1. Home
  2. PDM vs XNCR Comparison

PDM vs XNCR Comparison

Compare PDM & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDM
  • XNCR
  • Stock Information
  • Founded
  • PDM 1997
  • XNCR 1997
  • Country
  • PDM United States
  • XNCR United States
  • Employees
  • PDM N/A
  • XNCR N/A
  • Industry
  • PDM Building operators
  • XNCR Biotechnology: Pharmaceutical Preparations
  • Sector
  • PDM Real Estate
  • XNCR Health Care
  • Exchange
  • PDM Nasdaq
  • XNCR Nasdaq
  • Market Cap
  • PDM 1.3B
  • XNCR 1.5B
  • IPO Year
  • PDM N/A
  • XNCR 2013
  • Fundamental
  • Price
  • PDM $9.44
  • XNCR $23.07
  • Analyst Decision
  • PDM Strong Buy
  • XNCR Strong Buy
  • Analyst Count
  • PDM 2
  • XNCR 8
  • Target Price
  • PDM $11.00
  • XNCR $35.50
  • AVG Volume (30 Days)
  • PDM 903.1K
  • XNCR 498.6K
  • Earning Date
  • PDM 10-24-2024
  • XNCR 11-06-2024
  • Dividend Yield
  • PDM 5.30%
  • XNCR N/A
  • EPS Growth
  • PDM N/A
  • XNCR N/A
  • EPS
  • PDM N/A
  • XNCR N/A
  • Revenue
  • PDM $572,424,000.00
  • XNCR $85,164,000.00
  • Revenue This Year
  • PDM N/A
  • XNCR N/A
  • Revenue Next Year
  • PDM N/A
  • XNCR $86.53
  • P/E Ratio
  • PDM N/A
  • XNCR N/A
  • Revenue Growth
  • PDM N/A
  • XNCR N/A
  • 52 Week Low
  • PDM $5.78
  • XNCR $15.31
  • 52 Week High
  • PDM $11.12
  • XNCR $26.84
  • Technical
  • Relative Strength Index (RSI)
  • PDM 33.55
  • XNCR 62.73
  • Support Level
  • PDM $10.06
  • XNCR $23.05
  • Resistance Level
  • PDM $10.45
  • XNCR $24.04
  • Average True Range (ATR)
  • PDM 0.29
  • XNCR 0.83
  • MACD
  • PDM -0.10
  • XNCR 0.10
  • Stochastic Oscillator
  • PDM 1.53
  • XNCR 68.65

About PDM Piedmont Office Realty Trust Inc.

Piedmont Office Realty Trust Inc is a real estate investment trust engaged in the acquisition, development, and management of commercial real estate properties throughout the U.S. The company's real estate portfolio is mainly composed of office properties located in the majority of American metropolitan areas. Piedmont derives majority of its revenue in the form of rental income from tenants in mid- to long-term lease agreements. The vast majority of the company's revenue comes from the leasing of its assets in Washington D.C., New York City, Chicago, Atlanta, Minneapolis, Dallas, and Boston. Piedmont's large customers in terms of rental revenue are U.S. Government entities, business services companies, and financial institutions.

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.

Share on Social Networks: